Immediate Weight Bearing Versus Protected Weight Bearing in Supracondylar Distal Femur Fractures (WtBrFemFx)

June 2, 2022 updated by: David Hubbard, MD, West Virginia University

Immediate Weight Bearing as Tolerated Versus Protected Weight Bearing in Supracondylar Distal Femur Fractures; a Prospective, Randomized Study

This study is designed to examine if immediate weight bearing on a distal femur fracture fixed with a primary locking plate, either a distal condylar locking plate or a LISS (less invasive stabilization system), is safe and promotes more rapid fracture healing than partial weight bearing, which is standard of care.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This study is designed to examine if immediate weight bearing on a distal femur fracture fixed with a primary locking plate, either a distal condylar locking plate or a LISS (less invasive stabilization system), is safe and promotes more rapid fracture healing than partial weight bearing, which is standard of care. Historically and currently patients are kept partial weight bearing after fixation of these fractures for 6-12 weeks until callous formation is observed on radiographs. The hypothesis is that participants allowed to bear weight immediately will heal at least as quickly as those who have weight bearing status protected with the added benefits from early mobilization. Fracture healing will be monitored closely by follow up appointments and complications will be documented.

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Virginia
      • Morgantown, West Virginia, United States, 26506
        • West Virginia University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged > 18 yo
  • distal supracondylar femur fracture (Supracondylar distal femur fractures treated with a locked plate, either a distal condylar locking plate or a LISS (less invasive stabilization system), including peri-prosthetic fractures)
  • both male and female

Exclusion Criteria:

  • Patients with an intracondylar split,
  • polytrauma patients with associated trauma that will inhibit their ability to weight bear,
  • metastatic disease,
  • incomplete follow up,
  • subjects with questionable ability to bear weight (ie advanced dementia),
  • open fractures with bone loss.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Full Weight Bearing
Participants assigned to full weight bearing after fixation of distal femur fracture.
full weight bearing after fixation of a distal femur fracture
No Intervention: Partial Weight Bearing
Participants assigned to partial weight bearing, standard of care, after fixation of distal femur fracture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to Distal Femur Fracture Healing by Radiographic Evidence
Time Frame: up to 12 weeks
Radiographs were analyzed postoperatively to determine bridging of 3 or 4 cortices per standard of care during follow-up office visits.
up to 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to Ambulation
Time Frame: up to 24 weeks
Investigators measure time to ambulation
up to 24 weeks
Time of Participation in Physical Therapy
Time Frame: up to 1 year
Investigators measure the length of time of physical therapy participation
up to 1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Days to Discharge
Time Frame: Up to 30 days
Investigators record the number of days from surgery to discharge
Up to 30 days
Discharge Disposition
Time Frame: Up to 30 days
Investigators record the participants' discharge location, e.g. home, rehabilitation facility
Up to 30 days
Change in Pain
Time Frame: 2 days, 2 weeks, 6 weeks, 3 months, 6 months, 12 months
Investigators record the pain from 0-10 at each time point
2 days, 2 weeks, 6 weeks, 3 months, 6 months, 12 months
Change in Knee Society Score
Time Frame: 6 weeks, 3 months, 6 months, 12 months
Participants complete the Knee Society survey at the listed time points
6 weeks, 3 months, 6 months, 12 months
Knee Flexion
Time Frame: 12 months
Investigators measure knee flexion
12 months
Number of Participants With Non Union
Time Frame: 12 months
Investigators assess non union at 1 year
12 months
Number of Participants With Malunion
Time Frame: 12 months
Investigators assess malunion at 1 year
12 months
Number of Participants With Infection
Time Frame: 12 months
Investigators check for infection
12 months
Deep Vein Thrombosis at Each Time Point
Time Frame: 12 months
Investigators check for Deep Vein Thrombosis
12 months
Number of Participants With Pulmonary Embolism
Time Frame: 12 months
Investigators check for Pulmonary Embolism
12 months
Number of Participants With Implant Failure
Time Frame: 12 months
Investigators check for implant failure at 12 months
12 months
Change in Vit D Level in Age 65 and Older
Time Frame: baseline, 2 weeks, 6 weeks, 3 months, 6 months, 12 months
Investigators assess Vit D level in subject age 65 and older at all time points listed
baseline, 2 weeks, 6 weeks, 3 months, 6 months, 12 months
Study Mortality
Time Frame: 12 months
Investigators record any deaths at 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David F Hubbard, MD, West Virginia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2015

Primary Completion (Actual)

October 1, 2018

Study Completion (Actual)

October 1, 2018

Study Registration Dates

First Submitted

April 8, 2015

First Submitted That Met QC Criteria

May 23, 2017

First Posted (Actual)

May 25, 2017

Study Record Updates

Last Update Posted (Actual)

August 5, 2022

Last Update Submitted That Met QC Criteria

June 2, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 1408401969A

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

No individual participant data will be shared with other researchers. Shared group data will be presented at Orthopaedic conferences and through manuscript submission.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Closed Supracondylar Fracture of Femur

Clinical Trials on Full Weight Bearing

3
Subscribe